Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$784M |
| 2 |
Apple
AAPL
|
+$427M |
| 3 |
Danaher
DHR
|
+$417M |
| 4 |
Prologis
PLD
|
+$405M |
| 5 |
Amazon
AMZN
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWTR
Twitter, Inc.
TWTR
|
+$587M |
| 2 |
Eli Lilly
LLY
|
+$491M |
| 3 |
DRE
Duke Realty Corp.
DRE
|
+$343M |
| 4 |
ABMD
Abiomed Inc
ABMD
|
+$252M |
| 5 |
CTXS
Citrix Systems Inc
CTXS
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.43% |
| 3 | Financials | 13.92% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Industrials | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PGRE
1726
DELISTED
Paramount Group
PGRE
| $21.6M | ﹤0.01% |
3,629,544
+92,014
| +3% | +$575K |
|
1727
Rocket Pharmaceuticals
RCKT
$394M
| $21.6M | ﹤0.01% |
1,101,320
+242,101
| +28% | +$4.46M |
|
1728
Chefs' Warehouse
CHEF
$4.5B
| $21.5M | ﹤0.01% |
647,521
+29,513
| +5% | +$1.03M |
|
1729
FuelCell Energy
FCEL
$1.63B
| $21.5M | ﹤0.01% |
258,373
+16,081
| +7% | +$1.55M |
|
1730
Privia Health
PRVA
$2.87B
| $21.5M | ﹤0.01% |
947,365
+67,320
| +8% | +$1.87M |
|
1731
Encore Capital Group
ECPG
$2.13B
| $21.5M | ﹤0.01% |
448,394
+7,099
| +2% | +$342K |
|
1732
Brown-Forman Class A
BF.A
$13.3B
| $21.4M | ﹤0.01% |
326,003
+18,747
| +6% | +$1.28M |
|
1733
Andersons Inc
ANDE
$2.22B
| $21.4M | ﹤0.01% |
612,648
+11,170
| +2% | +$397K |
|
1734
Par Pacific Holdings
PARR
$3.32B
| $21.4M | ﹤0.01% |
921,256
+33,759
| +4% | +$735K |
|
1735
Remitly
RELY
$5.14B
| $21.3M | ﹤0.01% |
1,860,337
+104,843
| +6% | +$1.09M |
|
|
NTST
1736
NETSTREIT Corp
NTST
$2.1B
| $21.2M | ﹤0.01% |
1,157,650
+25,670
| +2% | +$479K |
|
1737
Triumph Financial Inc
TFIN
$1.82B
| $21.1M | ﹤0.01% |
432,440
+6,510
| +2% | +$352K |
|
|
LBAI
1738
DELISTED
Lakeland Bancorp Inc
LBAI
| $21.1M | ﹤0.01% |
1,199,122
+46,698
| +4% | +$833K |
|
1739
Stewart Information Services
STC
$2.08B
| $21.1M | ﹤0.01% |
494,001
+17,082
| +4% | +$715K |
|
1740
HNI Corp
HNI
$3.59B
| $21.1M | ﹤0.01% |
741,372
+18,321
| +3% | +$521K |
|
1741
Palomar
PLMR
$3.45B
| $21.1M | ﹤0.01% |
466,127
+15,856
| +4% | +$1.08M |
|
1742
AbCellera Biologics
ABCL
$2.12B
| $20.9M | ﹤0.01% |
2,067,513
+82,316
| +4% | +$951K |
|
|
FLNA
1743
Filana Therapeutics
FLNA
$48.1M
| $20.9M | ﹤0.01% |
708,792
+23,941
| +3% | +$860K |
|
|
LADR
1744
Ladder Capital
LADR
$1.24B
| $20.9M | ﹤0.01% |
2,080,926
+92,912
| +5% | +$963K |
|
1745
Mativ Holdings
MATV
$711M
| $20.8M | ﹤0.01% |
996,896
+49,584
| +5% | +$1.08M |
|
1746
Coursera
COUR
$1.54B
| $20.8M | ﹤0.01% |
1,759,611
+76,014
| +5% | +$958K |
|
|
DICE
1747
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $20.8M | ﹤0.01% |
666,826
+182,224
| +38% | +$5.94M |
|
|
SWTX
1748
DELISTED
SpringWorks Therapeutics
SWTX
| $20.8M | ﹤0.01% |
799,779
+180,885
| +29% | +$4.46M |
|
1749
Allegiant Air
ALGT
$2.57B
| $20.8M | ﹤0.01% |
305,940
+17,599
| +6% | +$1.28M |
|
1750
Southside Bancshares
SBSI
$967M
| $20.8M | ﹤0.01% |
577,926
+18,164
| +3% | +$644K |
|
Similar funds
Geode Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Geode Capital Management held 5,090 positions worth $713B, up 8.1% from $659B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Trading was light in Q4 2022: portfolio turnover was 4.9%. Geode Capital Management opened 62 new positions and exited 188, leaving the 5,090-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q4 2022 buy was Ferguson: 1,854,192 shares worth $235M.
- Geode Capital Management added most to Microsoft in Q4 2022, an estimated $784M increase.
- Geode Capital Management's biggest Q4 2022 reduction was Eli Lilly, cutting an estimated $491M.
- Geode Capital Management fully exited Twitter, Inc. in Q4 2022, selling an estimated $587M.
- Geode Capital Management's ten largest holdings make up 20% of its $713B portfolio in Q4 2022.
- Geode Capital Management opened 62 new positions and closed 188 in Q4 2022.
- Geode Capital Management's portfolio value rose 8.1% quarter-over-quarter to $713B.
Based on Geode Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.